CorpAcq SPAC Presentation Deck

2C 1 2 3 Significant New Capital to Accelerate Growth Churchill transaction provides capital to optimize CorpAcq's balance sheet and fuel future growth with a wider acquisition range Capital Raised in Churchill Transaction $592mm Cash in Trust Transaction Uses (1,2) Redeem preferred equity De-lever/fund cash to balance sheet Fund partial secondary to shareholders CHURCHILL CAPITAL VII CorpAcq Pro Forma Capital Structure) ($ in mm) Gross Debt Pro Forma Gross Debt / FY2023E Adj. EBITDA Pro Forma Cash(3) Net Debt Pro Forma Net Debt / FY2023E Adj. EBITDA Conservative Net Leverage Significant Dry Powder 1.8x Net Leverage(2,3,4) ~$199mm Cash on Balance Sheet(2,3) 467 3.1x 199 268 1.8x Source: CorpAcq and Churchill Capital Corp VII Management. Debt balances as of 5/31/2023, adjusted for acquisitions to be completed prior to July 31, 2023. Note: Financials based on UK GAAP audits and has not been audited in accordance with PCAOB standards. FY2023E financials are estimates from CorpAcq Management. Assumes USD:GBP exchange ratio of 1.286:1. (1) CVII cash-in-trust was US $592mm as of May 16, 2023. (2) Assumes no additional redemptions. (3) Pro forma cash balance assumes $71mm as of May 31, 2023 plus cash from trust after subtracting fees & expenses excluding taxes, redemption of CorpAcq preferred and then up to $257m of secondary proceeds; assumes no additional redemptions and a minimum of $129mm cash to the balance sheet before any secondary proceeds. (4) Net Leverage is calculated as Gross Debt - Pro Forma Cash / FY20223E Adj. EBTIDA. See appendix for the definition and reconciliation of Adj. EBITDA. 26

View entire presentation